What’s behind the peptide boom and why it matters to Switzerland

Peptides, a class of drugs made of short chains of amino acids, are in growing demand for everything from weight loss and muscle aches to longevity and rare cancers. This is good news for Switzerland, which is home to some of the largest peptide manufacturers in the world. On July 20, South Korean contract biopharmaceutical manufacturer Samsung Biologics announced plans to acquire Swiss company PolyPeptide in an all-cash deal for around CHF1.46 billion ($1.81 billion). This made it the largest…